Corpus ID: 9606247

Investigation of granulomatous prostatitis incidence following intravesical BCG therapy.

@article{Balasar2014InvestigationOG,
  title={Investigation of granulomatous prostatitis incidence following intravesical BCG therapy.},
  author={M. Balasar and M. Doğan and Abdulkadir Kandemir and H. Taskapu and Faruk Cicekci and H. Toy and R. Gurbuz},
  journal={International journal of clinical and experimental medicine},
  year={2014},
  volume={7 6},
  pages={
          1554-7
        }
}
  • M. Balasar, M. Doğan, +4 authors R. Gurbuz
  • Published 2014
  • Medicine
  • International journal of clinical and experimental medicine
  • UNLABELLED In the present manuscript, we studied the incidence of granulomatous prostatitis in the prostatectomy specimen of the patients who underwent transurethral resection of the prostate (TURP) after superficial bladder cancer treatment with intravesical Bacillus Calmette-Guerin (BCG) and were diagnosed with benign prostate hyperplasia (BPH). The clinical data and histopathological specimen records of 472 patients who underwent TUR-P due to BPH diagnosis, obtained over a period of 6 years… CONTINUE READING
    13 Citations
    [Bladder Rupture during Intravesical BCG Therapy : A Case Report].
    • PDF
    Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
    • 30
    • PDF
    Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
    • 12
    • PDF
    Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
    • 18
    • PDF
    Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies
    • 8
    • PDF

    References

    SHOWING 1-10 OF 20 REFERENCES
    Granulomatous prostatitis following bacillus Calmette-Guerin immunotherapy of bladder cancer.
    • 67
    Granulomatous prostatitis on needle biopsy.
    • 75
    The clinical spectrum of granulomatous prostatitis: a report of 200 cases.
    • 85
    Granulomatous prostatitis: distinction among allergic, nonspecific, and post-transurethral resection lesions.
    • 77
    Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.
    • 75
    • PDF
    Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin
    • 22